Search - tctmd.com

Displaying 461 - 480 of 1039

Sort: Relevancy | Date

News Conference News AHA 2015

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

Shelley Wood

November 08, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

Presentation TCT 2015

Debate: Should Our Patients Receive BRS Rather Than Metallic DES TODAY? Yes, the 1-Year Results Are Very Close, and the Late Outcomes Will Be Superior Our Patients Cant Wait for the Proof!

Presenter: Thomas F. Luscher, Gregg W. Stone, Ashok Seth

October 15, 2015

Presentation TCT 2015

Case Resolution: How We Treated a Clinically High-Risk and Anatomically Complex Left Main Patient (With Long-term Follow-up)

Presenter: Davide Capodanno, Gregg W. Stone, Nicholas J. Lembo

October 15, 2015

Presentation TCT 2015

Case Introduction: PCI or CABG? A Clinically High-Risk and Anatomically Complex Left Main Patient

Presenter: Davide Capodanno, Gregg W. Stone, Nicholas J. Lembo

October 15, 2015

Presentation TCT 2015

Who Should Undergo LM PCI Today? US and EU Guidelines and AUC Review

Presenter: Davide Capodanno, Gregg W. Stone, Ajay J. Kirtane

October 15, 2015

Presentation TCT 2015

Long-term Results of PCI vs CABG in 4,046 Patients With Left Main Disease: Fu Wai Experience

Presenter: Davide Capodanno, Gregg W. Stone, Bo Xu

October 15, 2015

Presentation TCT 2015

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Presenter: Davide Capodanno, Gregg W. Stone, Patrick W. Serruys

October 15, 2015

Presentation TCT 2015

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Presenter: Davide Capodanno, Gregg W. Stone, Jung-Min Ahn

October 15, 2015

Presentation TCT 2015

Possible Clinical Trial Designs to Demonstrate the Relative Benefits of BRS vs Permanent Platform DES

Presenter: Chuck Simonton, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

Incorporating Quality-of-Life and Patient-Oriented Outcomes in the Device Regulatory Approval Process

Presenter: Andrew Farb, Gregg W. Stone, John A. Spertus

October 14, 2015

Presentation TCT 2015

Key Elements of BRS Nonclinical Testing to Support IDE Approval

Presenter: Andrew Farb, Gregg W. Stone, Michael C. John

October 14, 2015

Presentation TCT 2015

Controversial Viewpoint: Characterizing BRS Class Effects BRS Designs Are More Different Than Alike (Regulatory Implications)

Presenter: Andrew Farb, Gregg W. Stone, Juan F. Granada

October 14, 2015

Presentation TCT 2015

Assessing Whether Superiority Exists: Design, Rationale, and Status of ABSORB IV

Presenter: Stephen G. Ellis, Patrick W. Serruys, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

Presenter: Stephen G. Ellis, Patrick W. Serruys, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

Presenter: Deepak L. Bhatt, Martin Rose, Gregg W. Stone

October 14, 2015

Presentation TCT 2015

When and How to Treat a Claudicant With an Occluded SFA

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Presenter: William A. Gray, Gregg W. Stone, D. Christopher Metzger, Sripal Bangalore

October 14, 2015

News Conference News TCT 2015

Shelley Wood to Join CRF as Editorial Director

October 14, 2015

News Conference News TCT 2015

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

October 14, 2015

Advertisement

Inappropriate PCIs Slashed by Half Since First AUC Released, But Key Questions Remain

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Debate: Should Our Patients Receive BRS Rather Than Metallic DES TODAY? Yes, the 1-Year Results Are Very Close, and the Late Outcomes Will Be Superior Our Patients Cant Wait for the Proof!

Case Resolution: How We Treated a Clinically High-Risk and Anatomically Complex Left Main Patient (With Long-term Follow-up)

Case Introduction: PCI or CABG? A Clinically High-Risk and Anatomically Complex Left Main Patient

Who Should Undergo LM PCI Today? US and EU Guidelines and AUC Review

Long-term Results of PCI vs CABG in 4,046 Patients With Left Main Disease: Fu Wai Experience

PCI vs CABG for LM Disease: New Insights From Syntax LM to Help Choose

Left Main PCI vs CABG: Fifteen-Year Results From the Asan Medical Center and 5-Year Results From PRECOMBAT

Possible Clinical Trial Designs to Demonstrate the Relative Benefits of BRS vs Permanent Platform DES

Incorporating Quality-of-Life and Patient-Oriented Outcomes in the Device Regulatory Approval Process

Key Elements of BRS Nonclinical Testing to Support IDE Approval

Controversial Viewpoint: Characterizing BRS Class Effects BRS Designs Are More Different Than Alike (Regulatory Implications)

Assessing Whether Superiority Exists: Design, Rationale, and Status of ABSORB IV

Featured Lecture: One-Year Patient-Level Pooled Meta-analysis From 4 ABSORB Trials in 3389 Randomized Patients

Identifying and Studying Data Gaps: Cangrelor Use What's Settled, and What's Not?

When and How to Treat a Claudicant With an Occluded SFA

Stable CAD With Substantial Ischemia and No-to-Mild Symptoms: Initial Revascularization vs Medical Therapy

Shelley Wood to Join CRF as Editorial Director

Paul S. Teirstein, MD, Receives 2015 Master Operator Award

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content